SCHEMBL3548124

SCHEMBL3548124

Cc1ccc(-c2oncc2C(=O)N2CCN(c3ccccc3)CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
ALDH1A1 P00352 5/20 0.53
USP2 O75604 1/20 0.53
TSHR P16473 1/20 0.53
HCRTR1 O43613 2/20 0.52
HCRTR2 O43614 2/20 0.52
TP53 P04637 3/20 0.50
MAPT P10636 2/20 0.50
POLB P06746 2/20 0.49
SLC6A7 Q99884 1/20 0.49
KDM4E B2RXH2 2/20 0.48
SCD O00767 1/20 0.48
SCD5 Q86SK9 1/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3544606 0.85 SLC6A7 (0.63) MEN1KMT2AALDH1A1TSHRHCRTR1
SCHEMBL3543510 0.84 KDM4E (0.63) MEN1KMT2AALDH1A1TSHRMAPT
SCHEMBL3186687 0.84 ALDH1A1 (0.54) MEN1KMT2AALDH1A1USP2TSHR
SCHEMBL3549632 0.82 ALDH1A1 (0.50) ALDH1A1USP2TSHRHCRTR1HCRTR2
SCHEMBL3553078 0.82 HCRTR1 (0.53) KMT2AALDH1A1TSHRHCRTR1HCRTR2
SCHEMBL3546337 0.81 CYP46A1 (0.56) MEN1KMT2AALDH1A1USP2TSHR
SCHEMBL3552122 0.81 HCRTR1 (0.50) ALDH1A1HCRTR1HCRTR2MAPTKDM4E
SCHEMBL14304942 0.80 HCRTR1 (0.46) ALDH1A1USP2TSHRHCRTR1HCRTR2
SCHEMBL13501704 0.80 CYP46A1 (0.51) MEN1KMT2AALDH1A1TSHRHCRTR1
SCHEMBL3540493 0.79 ALDH1A1 (0.51) MEN1KMT2AALDH1A1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7666888-B2 Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1 AMGEN INC. (US) 2010-02-23 US disclosed
US-7666888-B2 Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1 AMGEN INC. (US) 2010-02-23 US disclosed
US-7666888-B2 Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1 AMGEN INC. (US) 2010-02-23 US disclosed
EP-2051977-A2 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1 Amgen Inc. (US) 2009-04-29 EP disclosed
WO-2008011453-A2 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1 AMGEN INC. (US) 2008-01-24 WO disclosed
WO-2008011453-A2 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1 AMGEN INC. (US) 2008-01-24 WO disclosed
US-20080021022-A1 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF 11BETA-HSD-1 AMGEN INC. 2008-01-24 US disclosed
US-20080021022-A1 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF 11BETA-HSD-1 AMGEN INC. 2008-01-24 US disclosed
US-20080021022-A1 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF 11BETA-HSD-1 AMGEN INC. 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021022-A1 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF 11BETA-HSD-1 HSD17B1, HSD11B1, HSD17B11 MEN1 1658/4885KMT2A 2389/4885ALDH1A1 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.